|
Market Closed -
Nasdaq
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 37.88 USD | -4.27% |
|
-11.23% | -23.78% |
| 09-17 | Indivior Sets Special Cash Dividend at $8.13 a Share Contingent on Completion of Supernus Merger | MT |
| 08-03 | Supernus Pharmaceuticals, Inc. Revises Earnings Guidance for the Full Year 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -4.27% | -11.23% | -8.46% | -21.43% | -23.78% | -23.87% | +46.71% | +19.65% | +82.03% | 2.3B | |
| +0.43% | +6.59% | +10.48% | +7.51% | +16.97% | +53.41% | +103.85% | +428.43% | +1,485.76% | 1,116B | |
| +0.90% | -2.25% | -4.38% | +2.24% | +23.49% | +33.02% | +62.23% | +58.44% | +117.39% | 610B | |
| +0.71% | +3.24% | +8.73% | +12.20% | +24.92% | +25.81% | +93.86% | +161.06% | +374.36% | 501B | |
| -0.13% | +5.98% | +4.61% | +14.35% | +15.54% | +32.91% | +50.39% | +5.26% | +60.81% | 366B | |
| +0.52% | +0.24% | +0.72% | +14.35% | +38.66% | +73.92% | +40.15% | +86.33% | +134.87% | 358B | |
| -0.95% | +4.70% | +9.12% | +1.17% | +13.78% | +19.51% | +43.00% | +62.10% | +65.38% | 288B | |
| -1.98% | +3.73% | +2.55% | -1.44% | -9.75% | -0.86% | +13.43% | +41.51% | +151.59% | 261B | |
| -0.35% | +4.25% | +14.92% | +16.39% | +32.13% | +46.21% | +50.76% | +108.09% | +167.13% | 235B | |
| -0.75% | +3.32% | +5.76% | +14.59% | +27.25% | +32.53% | +97.21% | +130.95% | +114.69% | 195B | |
| -1.46% | +1.70% | -4.77% | -22.69% | -20.18% | -29.07% | -63.28% | -21.09% | +91.94% | 175B | |
| +0.48% | +4.60% | +7.72% | +17.66% | +18.80% | +22.08% | -11.09% | -28.71% | -9.43% | 168B | |
| -1.77% | -2.03% | -2.63% | +2.82% | +10.23% | +22.30% | +33.62% | +174.93% | +530.75% | 129B | |
| -1.35% | +1.07% | -6.05% | -1.26% | +10.77% | +37.70% | +4.51% | +2.38% | +20.05% | 124B | |
| +0.62% | +7.03% | +13.25% | +19.44% | +22.50% | +29.58% | +120.70% | +392.16% | +524.12% | 116B | |
| -0.32% | +6.43% | -0.16% | -4.78% | +2.08% | +13.98% | +24.73% | +6.46% | -11.89% | 99.22B | |
| -0.30% | +0.59% | -3.24% | -6.50% | -13.03% | -16.67% | -30.75% | -14.19% | +5.02% | 96.85B | |
| -7.82% | -3.11% | +49.71% | +245.23% | +639.27% | +703.28% | +137.12% | -32.76% | - | 94.42B | |
| -0.70% | +5.92% | +2.08% | +16.47% | +2.44% | +38.93% | -6.27% | +42.93% | +112.75% | 79.52B | |
| +0.73% | +4.68% | +9.57% | +4.60% | +17.70% | +29.01% | -3.38% | -24.98% | +47.94% | 69.78B | |
| Average | -0.58% | +2.79% | +5.48% | +16.55% | +42.49% | +57.19% | +40.38% | +79.95% | +213.96% | 254.17B | |
| Weighted average by Cap. | -0.05% | +3.92% | +5.77% | +11.41% | +28.55% | +46.15% | +58.67% | +150.43% | +454.09% |
- Stock Market
- Stocks
- SUPN Stock
- Sector Supernus Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
